BPC
ICPT

Banque Pictet & Cie’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Banque Pictet & Cie’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,000
Closed -$282K – 484
2015
Q1 		$282K Buy
+1,000
New +$217K 0.01% 393

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Banque Pictet & Cie's ICPT Position: Q2 2015 in Review

Banque Pictet & Cie sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 1,000 shares — an estimated $282K sold.

Banque Pictet & Cie first reported a position in ICPT in Q1 2015 and held it in 1 quarter. The position peaked at $282K in Q1 2015. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Banque Pictet & Cie reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Banque Pictet & Cie sold 1,000 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $282K.
  • Banque Pictet & Cie first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Banque Pictet & Cie's Intercept Pharmaceuticals, Inc. position peaked at $282K in Q1 2015.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Banque Pictet & Cie's 13F filing for Q2 2015, filed 7 Aug 2015.